Wells Fargo
SONM icon

Wells Fargo’s DNA X Inc SONM Stock Holding History

Wells Fargo’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$101 – 7422
2024
Q1 		$101 Hold
1
– – ﹤0.01% 6660
2023
Q4 		$115 Hold
1
– – ﹤0.01% 6732
2023
Q3 		$98 Hold
1
– – ﹤0.01% 6778
2023
Q2 		$163 Hold
1
– – ﹤0.01% 6756
2023
Q1 		$137 Hold
1
– – ﹤0.01% 6864
2022
Q4 		$56 Buy
+1
New +$82 ﹤0.01% 6978
2022
Q3 		– Sell
-1
Closed -$124 – 7300
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7429
2022
Q1 		$0 Hold
1
– – ﹤0.01% 7750
2021
Q4 		$0 Buy
+1
New +$304 ﹤0.01% 7760
2021
Q3 		– Hold
0
– – – 7468
2021
Q2 		– Hold
0
– – – 7390
2021
Q1 		– Hold
0
– – – 7329
2020
Q4 		– Hold
0
– – – 6972
2020
Q3 		– Hold
0
– – – 6852
2020
Q2 		– Sell
-10
Closed -$16K – 6769
2020
Q1 		$13K Buy
+10
New +$47.9K ﹤0.01% 5700
2019
Q4 		– Hold
0
– – – 6133
2019
Q3 		– Hold
0
– – – 6291
2019
Q2 		– Hold
0
– – – 6598

Other funds holding SONM

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Wells Fargo's SONM Position: Q2 2024 in Review

Wells Fargo sold out of DNA X Inc (SONM) in Q2 2024, closing a stake of 1 share — an estimated $101 sold.

Wells Fargo first reported a position in SONM in Q1 2020 and held it in 10 quarters. The position peaked at $13K in Q1 2020. 15 funds tracked by Wall St. Rank hold SONM as of Q2 2024.

  • Wells Fargo reported no remaining DNA X Inc position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 1 DNA X Inc share in Q2 2024, an estimated $101.
  • Wells Fargo first reported a position in DNA X Inc in Q1 2020 and held it in 10 quarters.
  • Wells Fargo's DNA X Inc position peaked at $13K in Q1 2020.
  • 15 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.